Literature DB >> 6653637

Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution.

D B Jack.   

Abstract

The Rosin Rammler Sperling Weibull distribution and its use in the analysis of complex data is explained with reference to metoprolol and acebutolol AUC values and isoniazid plasma concentrations. The technique is then applied to sparteine and debrisoquine data to resolve populations into distinct sub-groups. Goodness of fit is measured by applying the chi 2 test to the untransformed data. The method is simple to use and sub-groups can be identified rapidly. Each sub-group can be characterised by a simple exponential equation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653637     DOI: 10.1007/BF00542108

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  INDIVIDUAL VARIATIONS OF DRUG METABOLISM AS A FACTOR IN DRUG TOXICITY.

Authors:  D A EVANS
Journal:  Ann N Y Acad Sci       Date:  1965-03-12       Impact factor: 5.691

2.  Lack of evidence for polymorphism in metoprolol metabolism.

Authors:  D B Jack; M Wilkins; C P Quarterman
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

3.  Linearization of dissolution rate curves by the Weibull distribution.

Authors:  F Langenbucher
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

4.  A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

Authors:  D A Evans; A Mahgoub; T P Sloan; J R Idle; R L Smith
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

5.  A method for studying drug metabolism in populations: racial differences in amobarbital metabolism.

Authors:  W Kalow; B K Tang; D Kadar; L Endrenyi; F Y Chan
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

6.  Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians.

Authors:  N M Woolhouse; B Andoh; A Mahgoub; T P Sloan; J R Idle; R L Smith
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

7.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians.

Authors:  A Mahgoub; J R Idle; R L Smith
Journal:  Xenobiotica       Date:  1979-01       Impact factor: 1.908

9.  Evidence for a trimodal pattern of acetylation of isoniazid in uremic subjects.

Authors:  D J Chapron; M R Blum; P A Kramer
Journal:  J Pharm Sci       Date:  1978-07       Impact factor: 3.534

10.  The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab population.

Authors:  S I Islam; J R Idle; R L Smith
Journal:  Xenobiotica       Date:  1980-11       Impact factor: 1.908

View more
  5 in total

1.  A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plot.

Authors:  L Endrenyi; M Patel
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

2.  Distribution of xanthine oxidase activity in a Nigerian population.

Authors:  Ayorinde Adehin; Oluseye Oladotun Bolaji
Journal:  Eur J Clin Pharmacol       Date:  2015-05-05       Impact factor: 2.953

3.  Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing.

Authors:  P R Jackson; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 4.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

5.  Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values.

Authors:  Ayorinde Adehin; Oluseye O Bolaji
Journal:  BMC Res Notes       Date:  2018-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.